MedTrace Logo

Hyaluronic Acid and Articular Pain

NCT06814769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-02-07

No results posted yet for this study

Summary

This is a prospective longitudinal single-center clinical study on OA patients treated with HA . Patients will be enrolled at baseline (T0) and then monitored at 90 days (T1), 180 days (T2; ), and 360 days (T3). The first efficacy end-point will be the statistically significant difference (P\<0.05) in VAS scale between T2 and T0 and between T3 and T2

Conditions

Interventions

DEVICE

hyaluronic acid

intra-articular administration

Sponsors & Collaborators

  • University of Catanzaro

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-15
Primary Completion
2023-07-30
Completion
2024-12-20

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06814769 on ClinicalTrials.gov